# A Robust and Interpretable Pan-Cancer Multi-Omics Integration Framework for Generalisable Biomarker Discovery

## Overview

This repository presents a research portfolio exploring the proposed development of a robust and interpretable pan-cancer multi-omics integration framework for biomarker discovery.

The project was developed through a critical review of existing literature in multi-omics analysis, precision medicine, and explainable artificial intelligence. The review identified key challenges in current approaches, including limited interpretability, high-dimensional biological data complexity, batch effects, and insufficient validation across independent cohorts.

Based on these identified research gaps, this project proposes a 12-week research framework investigating how multi-omics integration methods can be designed to achieve a balance between predictive performance, biological interpretability, and generalisability. The proposed methodology combines robust preprocessing strategies, interpretable dimensionality reduction, machine learning and deep learning approaches, explainable AI techniques, and rigorous validation strategies.

This repository represents a research proposal and planned methodology; the proposed framework has not yet been implemented or experimentally evaluated. The aim of this research is to establish a foundation for developing trustworthy computational approaches that can support biomarker discovery and advance precision medicine.

---

## Objectives

The key objectives of this research project are:

- Identify limitations in existing pan-cancer multi-omics integration approaches through critical literature analysis.
- Develop a structured framework addressing challenges related to data variability, interpretability, and generalisability.
- Investigate preprocessing strategies including normalisation, missing data handling, and batch effect correction.
- Explore interpretable multi-omics integration techniques for extracting biologically meaningful representations.
- Compare traditional machine learning and advanced deep learning approaches for predictive modelling.
- Incorporate explainable AI methods to improve transparency and biomarker interpretation.
- Establish rigorous validation strategies for assessing model robustness across independent cohorts.

## Research Question

How can a pan-cancer multi-omics integration framework be designed to improve predictive performance, interpretability, and robustness through standardised preprocessing, explainable modelling approaches, and rigorous validation across independent cohorts for reliable biomarker discovery?

---

## Proposed Methodology

The proposed research framework follows a structured multi-stage pipeline designed to address key limitations in current multi-omics approaches, particularly challenges related to high-dimensional data, batch effects, interpretability, and generalisability.

### 1. Data Collection and Preprocessing

Multi-omics datasets will be collected from publicly available repositories, including TCGA, ICGC, and GEO. The preprocessing pipeline will include:

- Modality-specific normalisation to ensure consistency across datasets.
- Missing value imputation using robust statistical approaches.
- Batch effect correction to minimise technical variation between cohorts.

### 2. Multi-Omics Integration and Feature Representation

To reduce data complexity while preserving biological information:

- Feature selection methods will be applied to identify informative molecular features.
- Interpretable integration approaches, such as MOFA+ and Joint NMF, will be explored to generate meaningful low-dimensional representations.

### 3. Predictive Modelling and Benchmarking

The integrated representations will be evaluated using a range of machine learning and deep learning approaches, including:

- Logistic Regression as an interpretable baseline.
- Ensemble models such as Random Forest, XGBoost, and LightGBM.
- Deep learning approaches including neural networks, graph-based models, and transformer-based architectures.

This benchmarking strategy aims to understand the trade-off between predictive performance and model complexity.

### 4. Robust Validation Strategy

To assess model generalisability:

- Cross-validation strategies, including Leave-One-Cohort-Out (LOCO) validation, will be used to reduce data leakage and provide realistic performance estimates.
- Independent external cohorts will be used for final evaluation to assess robustness across different datasets.

### 5. Explainability and Biological Interpretation

Explainable AI techniques will be incorporated to improve transparency and identify biologically relevant features.

- SHAP-based methods will be used to analyse feature contributions.
- Dimensionality reduction visualisation methods such as UMAP and t-SNE will be applied to examine learned representations.
- Pathway analysis using approaches such as GSEA and KEGG enrichment will be explored to validate biological relevance.

---
